Ajanta Pharma Limited
AJANTPHARM
Classifica tra le azioni
#3706
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Prezzo delle azioni
$36.41
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$4.55B
Variazione (1 giorno)
-0.54%
Variazione (1 anno)
31.32%
Paese
IN
Scambia Ajanta Pharma Limited (AJANTPHARM)
Categoria
Healthcare
Rapporto P/S per Ajanta Pharma Limited (AJANTPHARM)
Rapporto P/S al October 2026 TTM: 7.22
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Ajanta Pharma Limited, il rapporto P/S attuale (TTM) è 7.22. Alla fine del 2024, era pari a 6.70.
Storico del rapporto P/S per Ajanta Pharma Limited da 2005 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 7.22 | 2.45% |
| 2025 | 7.05 | 5.24% |
| 2024 | 6.70 | 61.85% |
| 2023 | 4.14 | -13.17% |
| 2022 | 4.77 | -13.04% |
| 2021 | 5.48 | 17.77% |
| 2020 | 4.65 | 3.04% |
| 2019 | 4.52 | -24.60% |
| 2018 | 5.99 | -25.91% |
| 2017 | 8.08 | 11.33% |
| 2016 | 7.26 | -2.23% |
| 2015 | 7.43 | 150.83% |
| 2014 | 2.96 | 77.93% |
| 2013 | 1.66 | 110.13% |
| 2012 | 0.79 | 70.54% |
| 2011 | 0.46 | -11.05% |
| 2010 | 0.52 | 203.72% |
| 2009 | 0.17 | -43.53% |
| 2008 | 0.30 | -6.40% |
| 2007 | 0.33 | -12.74% |
| 2006 | 0.37 | 11.05% |
| 2005 | 0.34 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -2.29% |
IN
|
